Navin Fluorine Reports Strong Q2 & H1 FY26 Results, Announces Capex and Investor Meet
Navin Fluorine reported strong Q2 and H1 FY26 financial results with significant growth in revenue and profit. The company also announced capex plans for HFC and MPP capacity expansion and an upcoming investor meet.
The announcement includes strong financial results which directly influence investor perception and stock performance. Additionally, significant capex investments signal future growth potential and market expansion, while the investor meet provides direct engagement with the investment community, all of which are high-impact factors.
The company reported substantial year-on-year and quarter-on-quarter growth in revenue, operating EBITDA, PBT, and PAT for both Q2 and H1 FY26. The expansion of operating EBITDA margins and significant capex announcements for future growth in HFC and MPP capacities, alongside a robust order book for CDMO, indicate a strong positive outlook.
Navin Fluorine International Limited announced robust financial results for Q2 and H1 FY26, alongside significant capital expenditure plans and an upcoming investor meet. * Financial Highlights (Consolidated) for Q2 FY26 (ended September 30, 2025): * Net Revenue from Operations increased by 46.26% year-on-year to ₹758.42 crore. * Operating EBITDA surged by 129.32% year-on-year to ₹246.17 crore, with margins expanding to 32.46%. * Profit Before Tax (PBT) grew by 157.33% year-on-year to ₹197.50 crore. * Profit After Tax (PAT) rose by 152.24% year-on-year to ₹148.37 crore. * Financial Highlights (Consolidated) for H1 FY26: * Net Revenue from Operations increased by 42.37% year-on-year to ₹1,483.82 crore. * Operating EBITDA grew by 118.08% year-on-year to ₹452.96 crore, with margins at 30.53%. * Profit Before Tax (PBT) increased by 143.10% year-on-year to ₹352.61 crore. * Profit After Tax (PAT) increased by 141.36% year-on-year to ₹265.54 crore. * Capital Expenditure Announcements: * A capex of ₹236.5 crore for additional HFC capacity (up to 15,000 MTPA of R32), expected to be commissioned by Q3 FY27, with a peak revenue potential of ~₹600-825 crore per annum. * A capex of ₹75 crore for de-bottlenecking MPP capacity at Dahej to support a new molecule for a global innovator, targeted for commissioning by Q3 FY27, with a peak revenue potential of ~₹140-160 crore per annum. * Business Segment Performance: * HPP revenue grew 38% Y-o-Y in Q2 FY26, driven by higher realizations and volumes. AHF capex mechanical trials are underway, with commissioning by Q3 FY26. * Specialty Chemicals revenue grew 39% Y-o-Y in Q2 FY26, with a strong H2 outlook. * CDMO revenue saw a significant 98% Y-o-Y growth in Q2 FY26, with an order book pipeline until FY27. * Investor Meet: Company officials will interact with Analysts/Investors on November 05, 2025, at the B&K Securities | India Inc. Leaders Conference, involving physical one-on-one and group meetings.
What to do with a filing like this
Navin Fluorine International Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Navin Fluorine International Limited. Read the original for the full detail.